Zhichao Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhichao Zhang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Tingrui Pan
Suzhou Institute for Advanced Research, University of Science and Technology of China, Suzhou 215123, China
2 shared publications - Ben Bazor
TacSense, Inc., Woodland, California, United States
1 shared publication Chi-Wei Chang
Shenzhen Institutes of Advanced Technology, Institute of Biomedical and Health Engineering, Chinese Academy of Sciences, China
1 shared publication- Elahe Hosseini
Electrical and Computer Engineering, University of California Davis, Davis, California, USA
1 shared publication - Gozde Goncu-Berk
Design, University of California, Davis
1 shared publication - Houman Homayoun
University of California, Davis, Davis, CA, USA
1 shared publication
Latest Publications
- Open Access
- 21 June 2023
- Published by Association for Computing Machinery (ACM)
- p. 138-142
Short: Real-Time Bladder Monitoring by Bio-impedance Analysis to Aid Urinary Incontinence
The inability to sense the need to urinate is a persistent trouble for many individuals who have urinary incontinence. There are no products for people with urinary incontinence and their caregivers that target the elimination of involuntary urination instead of containing leaks or warning about leaks. Thus, fulfilling the real-time monitoring of the bladder to notify urination time holds a life-changing innovation potential for people with urinary incontinence. In this paper, we propose a low-cost wearable device in the form factor of an unobtrusive belt that uses bio-impedance measurement across the bladder region to notify the patients or caregivers about the need to urinate. We also present results from human subject tests using the proposed wearable prototype with a custom machine-learning algorithm to evaluate the accuracy of the system. Results from the human-subject tests showed an accuracy of over 90% on the binary task of full versus empty bladder states based on the change in bio-impedance values.
- 21 June 2023
- Published by Association for Computing Machinery (ACM)
- p. 138-142
Open AccessShort: Real-Time Bladder Monitoring by Bio-impedance Analysis to Aid Urinary Incontinence
The inability to sense the need to urinate is a persistent trouble for many individuals who have urinary incontinence. There are no products for people with urinary incontinence and their caregivers that target the elimination of involuntary urination instead of containing leaks or warning about leaks. Thus, fulfilling the real-time monitoring of the bladder to notify urination time holds a life-changing innovation potential for people with urinary incontinence. In this paper, we propose a low-cost wearable device in the form factor of an unobtrusive belt that uses bio-impedance measurement across the bladder region to notify the patients or caregivers about the need to urinate. We also present results from human subject tests using the proposed wearable prototype with a custom machine-learning algorithm to evaluate the accuracy of the system. Results from the human-subject tests showed an accuracy of over 90% on the binary task of full versus empty bladder states based on the change in bio-impedance values.
- 25 January 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 68 (9) , 2776-2786
iWRAP: A Theranostic Wearable Device With Real-Time Vital Monitoring and Auto-Adjustable Compression Level for Venous Thromboembolism
Objective: Venous Thromboembolism (VTE) is a commonly underdiagnosed disease with severe consequences and an exceedingly high mortality rate. Conventional compression wraps are devised for therapeutic purpose but lack diagnostic capacity. Recent advances in flexible electronics and wearable technologies offer many possibilities for chronic disease management. In particular, vital signs have been studied to show a strong correlation with the risk of VTE patients. In this study, we aim to develop an intelligent theranostic compression device, referred to as iWRAP, with the built-in capacity of real-time vital sign monitoring together with auto-adjustable compression level. Methods: An instantaneous pneumatic feedback control with a high-resolution pressure sensor is integrated to provide a highly stabilized compression level at the prescribed interface pressure for an improved therapeutic outcome. Meanwhile, arterial pulse waveforms extracted from the pressure readings from the smart compression device can be utilized to derive the body vital signs, including heart rate (HR), respiratory rate (RR) and blood pressure (BP). Results: A reliable delivery of the targeted compression level within ±5% accuracy in the range of 20-60 mmHg has been achieved through the feedback of the interface pressure. Both HR and RR have been measured within clinical-grade accuracies. Moreover, BP estimated using an ALA model has been achieved at low compression levels, which is also within a clinical-acceptable accuracy. The acquired vital information has been instantaneously fit into the clinically acceptable criteria for life-threatening PE risk with timely assessments. Conclusion: The iWRAP has shown the potential to become the first theranostic wearable device with both continuous delivery of accurate and effective compression therapy and real-time monitoring of life-threatening conditions for VTE patients.
- 25 January 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 68 (9) , 2776-2786
iWRAP: A Theranostic Wearable Device With Real-Time Vital Monitoring and Auto-Adjustable Compression Level for Venous Thromboembolism
Objective: Venous Thromboembolism (VTE) is a commonly underdiagnosed disease with severe consequences and an exceedingly high mortality rate. Conventional compression wraps are devised for therapeutic purpose but lack diagnostic capacity. Recent advances in flexible electronics and wearable technologies offer many possibilities for chronic disease management. In particular, vital signs have been studied to show a strong correlation with the risk of VTE patients. In this study, we aim to develop an intelligent theranostic compression device, referred to as iWRAP, with the built-in capacity of real-time vital sign monitoring together with auto-adjustable compression level. Methods: An instantaneous pneumatic feedback control with a high-resolution pressure sensor is integrated to provide a highly stabilized compression level at the prescribed interface pressure for an improved therapeutic outcome. Meanwhile, arterial pulse waveforms extracted from the pressure readings from the smart compression device can be utilized to derive the body vital signs, including heart rate (HR), respiratory rate (RR) and blood pressure (BP). Results: A reliable delivery of the targeted compression level within ±5% accuracy in the range of 20-60 mmHg has been achieved through the feedback of the interface pressure. Both HR and RR have been measured within clinical-grade accuracies. Moreover, BP estimated using an ALA model has been achieved at low compression levels, which is also within a clinical-acceptable accuracy. The acquired vital information has been instantaneously fit into the clinically acceptable criteria for life-threatening PE risk with timely assessments. Conclusion: The iWRAP has shown the potential to become the first theranostic wearable device with both continuous delivery of accurate and effective compression therapy and real-time monitoring of life-threatening conditions for VTE patients.
- 19 February 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 66 (11) , 3072-3079
FeetBeat: A Flexible Iontronic Sensing Wearable Detects Pedal Pulses and Muscular Activities
Objective: Human feet have long been considered in close association with whole-body health, from which abundant cardiovascular and skeletomuscular information can be extracted. In this study, we aim to develop the world's first foot-based wearable system that can detect both pedal pulses and muscular activities, referred to as FeetBeat. Methods: Utilizing the flexible iontronic sensing (FITS) technology, we have constructed and characterized a five-unit sensing array for detection of both pedal pulse signals and muscular activities. It is integrated into the tongue of an athletic shoe for real-time signal acquisition. Additionally, the linear array allows alignment-free capture of pulse signals and also provides a spatial reference to muscular activities. Results: An ultrahigh sensitivity of up to 1 nF/mmHg has been achieved for individual units, with a range of 1 to 200 mmHg. The pedal pulse waveforms have been detected to derive vital health signs, such as heart rates (HR) and respiratory rates, of which the pulse-derived HR is compared with the electrocardiogram (ECG). Moreover, individual tendon responses have been acquired to analyze different pedal gestures, from which multi-channel signals can be used to distinguish different activities. Conclusion: The FeetBeat device has shown the potential to be the world's first wearable platform to simultaneously analyze both vital signals and body activities from the measurable pedal pulse waveforms and muscular responses in a natural and unobtrusive fashion. The data-collecting wearable system provides a highly valuable means to assess the personalized health as well as daily activities on a continuous basis.
- 19 February 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 66 (11) , 3072-3079
FeetBeat: A Flexible Iontronic Sensing Wearable Detects Pedal Pulses and Muscular Activities
Objective: Human feet have long been considered in close association with whole-body health, from which abundant cardiovascular and skeletomuscular information can be extracted. In this study, we aim to develop the world's first foot-based wearable system that can detect both pedal pulses and muscular activities, referred to as FeetBeat. Methods: Utilizing the flexible iontronic sensing (FITS) technology, we have constructed and characterized a five-unit sensing array for detection of both pedal pulse signals and muscular activities. It is integrated into the tongue of an athletic shoe for real-time signal acquisition. Additionally, the linear array allows alignment-free capture of pulse signals and also provides a spatial reference to muscular activities. Results: An ultrahigh sensitivity of up to 1 nF/mmHg has been achieved for individual units, with a range of 1 to 200 mmHg. The pedal pulse waveforms have been detected to derive vital health signs, such as heart rates (HR) and respiratory rates, of which the pulse-derived HR is compared with the electrocardiogram (ECG). Moreover, individual tendon responses have been acquired to analyze different pedal gestures, from which multi-channel signals can be used to distinguish different activities. Conclusion: The FeetBeat device has shown the potential to be the world's first wearable platform to simultaneously analyze both vital signals and body activities from the measurable pedal pulse waveforms and muscular responses in a natural and unobtrusive fashion. The data-collecting wearable system provides a highly valuable means to assess the personalized health as well as daily activities on a continuous basis.